Scientists reported the development and characterization of a cell therapy alternative for drug-resistant mesial temporal lobe epilepsy, which was derived from a human embryonic stem cell line and comprises cryopreserved, post-mitotic, medial ganglionic eminence (MGE) pallial-type GABAergic interneurons.
[Cell Stem Cell]